Surgical device manufacturers asked to explain hike in prices of products

Surgiwear, has also been issued show cause notice for 12 products, including internal prosthetic implants, bone cement, eye dressing materials

Amid allegations that the National Capital Region (NCR)-based private hospitals were making profits from non-scheduled drug formulations and medical devices, the pharmaceutical pricing regulator is learnt to have sent show-cause notices to surgical product manufacturers, who have raised product prices by more than 10 per cent. Industry players, however, claim that the regulator needs to take a realistic view as they have merely rounded off the prices to make it less cumbersome for buyers. 

The National Pharmaceutical Pricing Authority (NPPA) has recently sent notices to surgical device makers, asking them to explain the rise in prices of their products by more